112
Participants
Start Date
December 31, 2015
Primary Completion Date
December 31, 2020
Study Completion Date
January 31, 2021
Ixazomib
Chemotherapy
Cyclophosphamide
Chemotherapy
Dexamethasone
Chemotherapy
Queen Elizabeth Medical Centre, Birmingham
Heart of England NHS Foundation Trust, Birmingham
Royal Bournemouth General Hospital, Bournemouth
University Hospital Bristol NHS Foundation Trust, Bristol
North Tees and Hartlepool NHS Foundation Trust, Hartlepool
Leeds Teaching Hospitals NHS Trust, Leeds
Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool
Barts and the London NHS Trust, London
University College London Hospitals NHS Foundation Trust, London
Guy's and St Thomas's NHS Foundation Trust, London
Royal Marsden Hospital, London
Imperial College Healthcare NHS Trust, London
The Christie NHS Foundation Trust, Manchester
Nottingham University Hospital NHS Trust, Nottingham
Churchill Hospital, Oxford
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Southampton University Hospital NHS Trust, Southampton
The Royal Wolverhampton Hospital NHS Trust, Wolverhampton
Collaborators (1)
Myeloma UK
OTHER
Millennium Pharmaceuticals, Inc.
INDUSTRY
University of Leeds
OTHER